The American Journal of Health Economics articles examine policies to address opioid crisis

Inhalers prescribed to Centers for Medicare & Medicaid Services (CMS) beneficiaries for asthma and chronic obstructive pulmonary disease resulted in estimated emissions of greenhouse gases

The partnership aims to boost GSK’s commitment to double Shingrix sales globally. Credit: MAXSHOT.PL/Shutterstock.com. GSK and Chongqing Zhifei Biological Products (Zhifei) have signed an exclusive

Clear­side Bio­med­ical re­port­ed pos­i­tive re­sults from a Phase 2b tri­al of its ty­ro­sine ki­nase in­hibitor in pa­tients with wet age-re­lat­ed mac­u­lar de­gen­er­a­tion, bol­ster­ing its prospects